Oct 23, 2026
Why Is Tango Therapeutics Stock Trading Lower After Cancer Drug Data?

Tango Therapeutics Inc. (NASDAQ:TNGX) on Friday shared Phase 1/2 trial data for its investigational drug vopimetostat, revealing strong efficacy in treating advanced pancreatic and lung cancers. The biotechnology firm reported marked tumor shrinkage when combining the PRMT5 inhibitor with Revolution…

Oct 23, 2026
8 Of 11 Sectors Fall In Friday Trading As Energy Leads

Three sectors are higher and eight are lower in Friday’s regular session, with Energy, Technology and Real Estate holding the top three positions across different market groups. The leaders are separated rather than clustered, with Energy well ahead of the…

Oct 23, 2026
Crown Castle Stock Jumps as SpaceX Targets 80,000 Sites

Crown Castle Inc. (NYSE:CCI) shares are gaining Thursday on reports that SpaceX is negotiating tower leases with the company as it hunts for at least 80,000 U.S. cell sites. Crown Castle shares are powering higher. Why is CCI stock surging?…

Oct 23, 2026
AST SpaceMobile Stock Under Pressure: SpaceX Competition, ViaSat Dispute

AST SpaceMobile Inc. (NASDAQ:ASTS) stock recovers after a morning decline. Investors are weighing intensifying competition from Space Exploration Technologies Corp (NASDAQ:SPCX), broader weakness across space stocks, a regulatory spectrum challenge from ViaSat, Inc. (NASDAQ:VSAT) and a pending securities class action.…

Oct 23, 2026
AT&T Stock Tumbles as SpaceX Eyes 80,000 Cell Sites

AT&T Inc. (NYSE:T) shares are sliding Thursday after a report that SpaceX wants access to at least 80,000 cell sites across the U.S., a prospect that is stoking competition fears for wireless carriers. AT&T stock is showing notable weakness. What’s…

Oct 23, 2026
Booz Allen Stock Slides As Government Contract Delays Hammer Civil Business

Booz Allen Hamilton Holding Corp. (NYSE:BAH) stock fell Friday despite the technology consulting company reporting better-than-expected second-quarter fiscal 2027 earnings and raising its full-year profit outlook.Revenue missed Wall Street estimates as slower government procurement and weakness in the company’s civil…